Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.,International Journal of Neuropsychopharmacology

当前位置： X-MOL 学术 › Int. J. Neuropsychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.
International Journal of Neuropsychopharmacology ( IF 4.8 ) Pub Date : 2020-07-21 , DOI: 10.1093/ijnp/pyaa052
Yuzuru Kataoka ₁ , Takamitsu Shimada ₁ , Yoko Koide ₁ , Hiroaki Okubo ₁ , Takashi Uehara ₁ , Toshiki Shioiri ₂ , Yasuhiro Kawasaki ₁ , Kazutaka Ohi _{1,

2,

3}

Affiliation

Patients with schizophrenia (SCZ) display impaired executive functions compared with healthy controls (HCs). Furthermore, unaffected first-degree relatives (FRs) of patients with SCZ independently perform worse executive functions than do HCs. However, few studies have investigated the differences in executive functions assessed among patients with SCZ, FRs, and HCs, and the findings are inconsistent.

中文翻译：

精神分裂症患者、其未受影响的一级亲属和健康参与者执行功能的差异。

与健康对照者 (HC) 相比，精神分裂症 (SCZ) 患者的执行功能受损。此外，SCZ 患者未受影响的一级亲属 (FR) 的独立执行功能比 HC 更差。然而，很少有研究调查 SCZ、FR 和 HC 患者执行功能评估的差异，并且结果不一致。

更新日期：2020-07-22

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>